GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (OTCPK:CHJTF) » Definitions » Cyclically Adjusted Revenue per Share

CHJTF (CSPC Pharmaceutical Group) Cyclically Adjusted Revenue per Share : $0.27 (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

CSPC Pharmaceutical Group's adjusted revenue per share for the three months ended in Dec. 2024 was $0.074. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.27 for the trailing ten years ended in Dec. 2024.

During the past 12 months, CSPC Pharmaceutical Group's average Cyclically Adjusted Revenue Growth Rate was 7.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of CSPC Pharmaceutical Group was 9.20% per year. The lowest was 8.20% per year. And the median was 8.40% per year.

As of today (2025-05-18), CSPC Pharmaceutical Group's current stock price is $0.64. CSPC Pharmaceutical Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was $0.27. CSPC Pharmaceutical Group's Cyclically Adjusted PS Ratio of today is 2.37.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CSPC Pharmaceutical Group was 7.74. The lowest was 2.00. And the median was 4.86.


CSPC Pharmaceutical Group Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for CSPC Pharmaceutical Group's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Cyclically Adjusted Revenue per Share Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.21 0.23 0.22 0.27

CSPC Pharmaceutical Group Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.27 0.29 0.22 0.27

Competitive Comparison of CSPC Pharmaceutical Group's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's Cyclically Adjusted PS Ratio falls into.


;
;

CSPC Pharmaceutical Group Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CSPC Pharmaceutical Group's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.074/114.8925*114.8925
=0.074

Current CPI (Dec. 2024) = 114.8925.

CSPC Pharmaceutical Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 0.031 99.900 0.036
201506 0.033 99.500 0.038
201509 0.033 100.500 0.038
201512 0.035 100.600 0.040
201603 0.033 102.200 0.037
201606 0.037 101.400 0.042
201609 0.035 102.400 0.039
201612 0.039 102.600 0.044
201703 0.038 103.200 0.042
201706 0.040 103.100 0.045
201709 0.043 104.100 0.047
201712 0.044 104.500 0.048
201803 0.057 105.300 0.062
201806 0.057 104.900 0.062
201809 0.063 106.600 0.068
201812 0.046 106.500 0.050
201903 0.068 107.700 0.073
201906 0.069 107.700 0.074
201909 0.066 109.800 0.069
201912 0.064 111.200 0.066
202003 0.073 112.300 0.075
202006 0.076 110.400 0.079
202009 0.081 111.700 0.083
202012 0.073 111.500 0.075
202103 0.086 112.662 0.088
202106 0.092 111.769 0.095
202109 0.088 112.215 0.090
202112 0.095 113.108 0.096
202203 0.104 114.335 0.105
202206 0.097 114.558 0.097
202209 0.094 115.339 0.094
202212 0.090 115.116 0.090
202303 0.098 115.116 0.098
202306 0.094 114.558 0.094
202309 0.090 115.339 0.090
202312 0.090 114.781 0.090
202403 0.105 115.227 0.105
202406 0.085 114.781 0.085
202409 0.077 115.785 0.076
202412 0.074 114.893 0.074

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


CSPC Pharmaceutical Group  (OTCPK:CHJTF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

CSPC Pharmaceutical Group's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.64/0.27
=2.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CSPC Pharmaceutical Group was 7.74. The lowest was 2.00. And the median was 4.86.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


CSPC Pharmaceutical Group Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group Business Description

Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C and antibiotics.

CSPC Pharmaceutical Group Headlines

From GuruFocus

Value Partners Classic Fund Comments on CSPC Pharmaceutical

By Vera Yuan Vera Yuan 07-29-2014